Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Equillium stock

Learn how to easily invest in Equillium stock.

Equillium Inc is a biotechnology business based in the US. Equillium shares (EQ) are listed on the NASDAQ and all prices are listed in US Dollars. Equillium employs 45 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Equillium

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EQ – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Equillium stock price (NASDAQ: EQ)

Use our graph to track the performance of EQ stocks over time.

Equillium shares at a glance

Information last updated 2022-09-18.
Latest market close$2.01
52-week range$1.66 - $7.12
50-day moving average $2.45
200-day moving average $3.06
Wall St. target price$12.83
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.25

Buy Equillium shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Equillium stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Equillium price performance over time

Historical closes compared with the close of $2.01 from 2022-09-23

1 week (2022-09-19) -11.45%
1 month (2022-08-26) -31.40%
3 months (2022-06-24) 18.24%
6 months (2022-03-25) -38.34%
1 year (2021-09-24) -70.91%
2 years (2020-09-25) -65.04%
3 years (2019-09-26) 3.91
5 years (2017-09-22) N/A

Equillium financials

Gross profit TTM $0
Return on assets TTM -37.03%
Return on equity TTM -115.88%
Profit margin 0%
Book value $1.17
Market capitalisation $77.6 million

TTM: trailing 12 months

Equillium share dividends

We're not expecting Equillium to pay a dividend over the next 12 months.

Equillium share price volatility

Over the last 12 months, Equillium's shares have ranged in value from as little as $1.66 up to $7.12. A popular way to gauge a stock's volatility is its "beta".

EQ.US volatility(beta: 1.23)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Equillium's is 1.2274. This would suggest that Equillium's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Equillium overview

Equillium, Inc. , a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017.

Frequently asked questions

What percentage of Equillium is owned by insiders or institutions?
Currently 31.902% of Equillium shares are held by insiders and 37.836% by institutions.
How many people work for Equillium?
Latest data suggests 45 work at Equillium.
When does the fiscal year end for Equillium?
Equillium's fiscal year ends in December.
Where is Equillium based?
Equillium's address is: 2223 Avenida De La Playa, La Jolla, CA, United States, 92037
What is Equillium's ISIN number?
Equillium's international securities identification number is: US29446K1060
What is Equillium's CUSIP number?
Equillium's Committee on Uniform Securities Identification Procedures number is: 29446K106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site